心肺复苏图表及心电监护评分标准,纯图可保存!

2022-04-19 华夏影像诊断中心 华夏影像诊断中心

收藏学习~

图片

图片

图片

 

图片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2117411, encodeId=de43211e411ee, content=希望有最新的版本出现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e68567924, createdName=苍莽, createdTime=Fri Mar 03 22:29:03 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1684592, encodeId=5fe51684592c2, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Tue Jun 07 10:50:53 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305534, encodeId=b8281305534b2, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551223, encodeId=79b81551223c5, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=)]
    2023-03-03 苍莽 来自广东省

    希望有最新的版本出现。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2117411, encodeId=de43211e411ee, content=希望有最新的版本出现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e68567924, createdName=苍莽, createdTime=Fri Mar 03 22:29:03 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1684592, encodeId=5fe51684592c2, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Tue Jun 07 10:50:53 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305534, encodeId=b8281305534b2, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551223, encodeId=79b81551223c5, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=)]
    2022-06-07 aids222
  3. [GetPortalCommentsPageByObjectIdResponse(id=2117411, encodeId=de43211e411ee, content=希望有最新的版本出现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e68567924, createdName=苍莽, createdTime=Fri Mar 03 22:29:03 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1684592, encodeId=5fe51684592c2, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Tue Jun 07 10:50:53 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305534, encodeId=b8281305534b2, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551223, encodeId=79b81551223c5, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=)]
    2022-04-21 lizhou0204
  4. [GetPortalCommentsPageByObjectIdResponse(id=2117411, encodeId=de43211e411ee, content=希望有最新的版本出现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e68567924, createdName=苍莽, createdTime=Fri Mar 03 22:29:03 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1684592, encodeId=5fe51684592c2, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Tue Jun 07 10:50:53 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305534, encodeId=b8281305534b2, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551223, encodeId=79b81551223c5, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Thu Apr 21 01:50:53 CST 2022, time=2022-04-21, status=1, ipAttribution=)]
    2022-04-21 bioon6

相关资讯

JAMA:儿童心脏骤停患者心肺复苏过程中血压因素对患儿预后的影响

在儿童心脏骤停心肺复苏过程中,考虑骤停期舒张压以及循环恢复后收缩压水平不会对改善患儿神经预后有显著影响

尽管长时间复苏会可引起进行性的代谢紊乱,但体外心肺复苏仍可提高存活率

对难治性心室颤动/室性心动过速而发生院外心脏骤停进行ECPR的患者,研究复苏时间对存活率和代谢状况的影响。

JAHA:儿童重症监护病房的重症儿童心肺复苏的流行病学特征

这项来自英国的多中心研究数据为进一步研究提供了基础,并为预防PICU心脏骤停提供了基准和质量改进的证据。

Neurology:心肺复苏后预测不良结局的NSE阈值

血清神经元特异性烯醇化酶(NSE)作为预测缺氧性脑损伤预后的生物标志物,在过去20年中一直是许多研究的主题。

Crit Care:肾上腺素对心肺复苏期间脑血管和全身血流动力学的影响

该模型表明肾上腺素可增加CBF和脑组织氧合作用,但在第三次注射后效果减弱。神经系统健康参数的无创测量为开发和指导复苏策略提供了希望。